Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Arkema S.A. (ARKAY)
OTHER OTC:ARKAY
Holding ARKAY?
Track your performance easily
ARKAY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$84.69 - $113.88
Previous Close$86.68
Volume706.00
Average Volume (3M)3.39K
Market Cap
$6.27B
Enterprise Value$8.38B
Total Cash (Recent Filing)€1.59B
Total Debt (Recent Filing)€3.26B
Price to Earnings (P/E)17.8
Beta1.02
Next Earnings
Feb 27, 2025EPS Estimate
$1.95Last Dividend Ex-Date
May 15, 2024Dividend Yield3.67%
Share Statistics
EPS (TTM)4.87
Shares OutstandingN/A
10 Day Avg. Volume8,679
30 Day Avg. Volume3,390
Standard Deviation0.10
R-Squared0.47
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.57
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Arkema SA News
PremiumCompany Announcements
Arkema’s Strong Performance Amidst Challenging Conditions
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
ARKAY FAQ
What was Arkema S.A.’s price range in the past 12 months?
Arkema S.A. lowest stock price was $84.69 and its highest was $113.88 in the past 12 months.
What is Arkema S.A.’s market cap?
Currently, no data Available
When is Arkema S.A.’s upcoming earnings report date?
Arkema S.A.’s upcoming earnings report date is Feb 27, 2025 which is in 106 days.
How were Arkema S.A.’s earnings last quarter?
Arkema S.A. released its earnings results on Nov 06, 2024. The company reported $2.395 earnings per share for the quarter, missing the consensus estimate of $2.531 by -$0.136.
Is Arkema S.A. overvalued?
According to Wall Street analysts Arkema S.A.’s price is currently Overvalued.
Does Arkema S.A. pay dividends?
Arkema S.A. pays a Annually dividend of $3.15 which represents an annual dividend yield of 3.67%. See more information on Arkema S.A. dividends here
What is Arkema S.A.’s EPS estimate?
Arkema S.A.’s EPS estimate is $1.95.
How many shares outstanding does Arkema S.A. have?
Arkema S.A. has 76,060,830 shares outstanding.
What happened to Arkema S.A.’s price movement after its last earnings report?
Arkema S.A. reported an EPS of $2.395 in its last earnings report, missing expectations of $2.531. Following the earnings report the stock price went up 1.251%.
Which hedge fund is a major shareholder of Arkema S.A.?
Currently, no hedge funds are holding shares in ARKAY
---
Arkema SA Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-7.41%
12-Months-Change
Fundamentals
Return on Equity
5.26%
Trailing 12-Months
Asset Growth
13.04%
Trailing 12-Months
Company Description
Arkema S.A.
Arkema SA engages in manufacturing and supply of chemical products. It operates through followings segments: High Performance Materials, Industrials Specialties and Coating Solutions. The High Performance Materials segment includes the Technical Polymers, Filtration and Adsorption and Organic Peroxides business units and provides solutions with high value added, used in varied sectors such as transportation, oil extraction, renewable energies, consumer goods, electronics, construction, coatings and water treatment. The Industrials Specialties segment groups the following business units: thiochemicals, fluorochemicals, polymethyl methacrylate and hydrogen peroxides. The Coating Solutions segment proposes solutions for decorative paints, industrial coatings, adhesives and high-growth acrylic applications. The company was founded on January 31, 2003 and is headquartered in Colombes, France.
---
ARKAY Company Deck
---
ARKAY Earnings Call
Q3 2024
0:00 / 0:00
---
Technical Analysis
---